Breakout Ventures — Full Portfolio

Twelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology.

Advanced ManufacturingCleantechClimate TechHealthtechNew MaterialsMoses Lake, US

NFNicholas Flanders(Founder)inECEtosha Cave(Founder)inKendra Kuhl(Founder)inACAndrew Cleeland(Executive Officer, Director)in

BoardMarc-Henri Galletti(Director)Nimesh Shah(Director)

Co-investorsDCDCVC (Data Collective)DODolby Family VenturesFIFifth WallADAdvantage Partners Inc.AEAera VCBRBreakout Labs+36 more

Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.

BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

ASAjay Shah(Founder)inHTHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)

BoardJFJack Fuchs(Director, Promoter)in

Board seatLindy Fishburne· per SEC Form D

Co-investorsALAlumni VenturesBABasecamp FundBLBlackhorn VenturesBRBreakout LabsDODolby Family VenturesEMEMV Capital+6 more

Aquaporo manufactures drinking water directly from atmospheric humidity using proprietary ALMA technology, offering residential units (Droplet) and industrial modular systems (Stream) for on-site water production.

CleantechHardwareAnaheim, US

Kyle E. Cordova(Founder)in

BoardKristopher H Gilman(Director)

Board seatLindy Fishburne· per SEC Form D

Co-investorsCECerberus VenturesCOCool Climate CollectiveE8E8 AngelsHUHumba Ventures

Checkerspot uses microalgae precision fermentation to produce specialized lipids and fats, including a bio-equivalent source of the sn-2 palmitate fat found in mother's milk, rare bioactive fatty acids, and tropical fat alternatives.

BiotechClimate TechFoodTechNew MaterialsAlameda, US

Scott Franklin(Executive Officer, Director)inCDCharles Dimmler(Executive Officer, Director)inJKJohn Krzywicki(CEO)inLWLayla Ward(CFO)inCLCasey Lippmeier(CTO)inLPLeon Parker(SVP, Molecular Biology)in

Board seatJMJulia Moore· per SEC Form D

Co-investorsBABaruch Future VenturesCACavallo VenturesKDKdT VenturesPLPlug and Play VenturesVIViking GlobalBUBuilders VC+5 more

Surf Bio is a preclinical biopharmaceutical company developing its SnapShot technology, which uses a proprietary polymer to create ultra-high-concentration antibody and biologic formulations (600+ mg/mL, doses over 1,000 mg) for delivery via a standard autoinjector.

BiotechDeep TechHealthtechPalo Alto, US

Jennifer Schneider(Executive Officer, Director)Ben Askew(Director)Bryan Mazlish(Chief Executive Officer, co-founder)inJSJennifer Schneider, MD(Co-founder, President & Chief Medical Officer)in

Board seatLindy Fishburne· per SEC Form D

Co-investorsPAPantera Capital

STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients.

BiotechDeep TechHealthtechLongevityMedical Devices

MLMichael Luther(CEO)in

Co-investorsASAscension VenturesBRBreakout LabsDEDelos CapitalGAGaingelsKDKdT VenturesNYNYBC Ventures+2 more

A-Alpha Bio uses synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions for pharmaceutical discovery and development.

AI & Machine LearningBiotechDeep TechSeattle, US

DYDavid Younger, PhD(Chief Executive Officer & Co-Founder)Randolph Lopez, PhD(Chief Technology Officer & Co-Founder)DYDavid Younger(Founder)inRLRandolph Lopez(Founder)in

Co-investorsANAngel Collective Opportunity FundFAFarvatn VentureLULux CapitalMAMadrona Venture GroupPLPlanet 9 CapitalBOBoom Capital+2 more

Canaery develops a nose-computer interface that combines animal olfaction with neurotechnology and AI to detect substances and diagnose diseases.

AI & Machine LearningBiotechDeep TechHardwareMedical Devices

Gabriel(Chief Executive Officer)Peter(Chief Technology Officer)

BoardDmitry(Chief Science Advisor)

Co-investors1515th RockFLFlorida Opportunity FundGOGood News VenturesNYNYU Innovation Venture FundDODolby Family VenturesKDKdT Ventures

CellChorus develops a visual AI platform called TIMING that performs high-throughput dynamic analysis of single cells, measuring cell activation, killing, and movement over time for biopharmaceutical research.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesHouston, US

DMDan Meyer(Founder)inNVNavin Varadarajan(Founder)inLCLaurence Cooper(Co-founder & Board Chair)inRBRebecca Berdeaux(Chief Scientific Officer)in

Co-investorsHOHouston Angel NetworkTETexas HALO FundY Y CombinatorASAsymmetry Ventures

Constellation develops foundation models of human state aimed at understanding brains, bodies, and environments.

AI & Machine LearningDeep TechHealthtech

Co-investorsMAMaC Venture Capital

Copernic develops catalysts for zero-carbon ammonia and e-fuels that are cost-competitive and compatible with existing industrial infrastructure.

CleantechClimate TechDeep TechEnergyCambridge, US

Aruna Ramkrishnan(Founder)inJacob Ebenstein Grose(Executive Officer, Director)

BoardLFLindy Fishburne(Director)inMKMichael Kearney(Director)inMichael LoCascio(Director)

Co-investorsFUFuture VenturesINInnospark VenturesJUJuniperNENew Climate VenturesTHThe Engine Ventures

Ecovative grows whole-cut meat alternatives and leather-like materials from mycelium using its AirMycelium indoor cultivation platform, which integrates with existing mushroom farming infrastructure.

BiotechFoodTechNew MaterialsGreen Island, US

EBEben Bayer(Cofounder)inGMGavin McIntyre(Founder)in

BoardEvan Lodes(Director)Jerry Weinstein(Director)Charles Deull(Director)Jessica Harris(Director)

Co-investorsBRBreakout LabsCOCool Climate CollectiveSTStray Dog CapitalTRTrousdale VenturesVIViking GlobalAIAiiM Partners+3 more

En Plus One Bio develops synthesis and manufacturing technology for RNA therapeutics, focused on producing high-purity long RNA with higher cycle efficiencies and novel chemical modifications.

BiotechDeep TechWatertown, US

DADaniel Ahlstedt(Executive Officer, Director)inJRJonathan Rittichier(Founder)inDaniel Wiegand(Founder)George M. Church(Founder)

BoardPMPaxton Major(Director)inALAndrew Lee(Director)in

Co-investorsCOCoatue ManagementNONorthpond Ventures

Epana Bio develops therapies for autoimmune diseases by leveraging genomics and AI to identify and target cellular origins of disease, with a focus on precision medicine for patient populations.

AI & Machine LearningBiotechDigital Health

Co-investorsBRBreakout LabsHAHAWKTAILHUHummingbird VenturesKDKdT VenturesOMOMX VenturesPOPoint Financial Capital+2 more

Fountain offers a high-volume hiring platform that lets candidates apply from their phones and provides automated workflows and analytics for enterprise recruitment teams.

AI & Machine LearningEnterprise SoftwareHR TechMarketplacesSaaSSan Francisco, US

KRKeith Ryu(CEO)inJCJeremy Cai(Founder)inJacqueline Senczyszyn(Recruiter)Ryan Huo(Recruiting Coordinator)Josh Harrisking(Manager, Project Management)Taylor Cotey(Recruiter)

Co-investorsB B Capital GroupB4B4 CapitalBLBling CapitalCOCommerce VenturesCRCrosslink CapitalDCDCM Ventures+26 more

General Sense develops detection technology that augments trained detection animals, aiming to identify molecular threats such as narcotics, crop diseases, human diseases, and bioweapons.

BiotechDeep TechDefense TechHardware

Peter Ledochowitsch(CTO & Co-Founder)inWDWestley Dang(CEO)in

Co-investors1515th RockDODolby Family VenturesDRDraper AssociatesJUJuniperKDKdT VenturesSOSOSV

Vitra Bio is a biotechnology company developing technology aimed at transforming fertility treatment.

BiotechFemTechHealthtech

Ivana Muncie-Vasic(Chief Executive Officer and Founder)inJLJohn Langowski(Chief Technology Officer)in

Co-investorsFOForeground CapitalNONorth South VenturesSPSpacecadet VenturesBOBoom Capital VenturesRERefactor Capital

Immusoft develops a cell therapy platform called Immune System Programming (ISP) that engineers a patient's B cells into plasma cells that produce therapeutic proteins after being infused back into the patient.

BiotechDeep TechHealthtechSeattle, US

MSMatthew Scholz(Founder)inSASean Ainsworth(Chief Executive Officer)inRSRobert Sikorski(Chief Medical Officer)RHRob Hayes(Chief Scientific Officer)inSMScott McIvor(Chief Development Officer)Eric Garcia(Executive Officer)in

Co-investorsBIBioRock VenturesBOBoston Harbor AngelsEQEQx FundINInvariantes FundMIMichigan Capital NetworkNYNYBC Ventures+6 more

Kisan Network operates a technology-enabled, integrated agricultural produce supply chain across India, connecting small and marginal farmers directly with businesses through a proprietary digital management portal.

Advanced ManufacturingAgTechB2B MarketplacesLogistics & Supply ChainGurugram, IN

AAAditya Agarwalla(CEO)inSKSanjay Kumar Agarwalla(Founder)inKisan Network HR(HR \u0026 Recruiting)

Co-investorsY Y CombinatorAGAgrolimen VenturesBEBEENEXTFUFundersClubLYLynett Capital PartnersMIMistletoe+2 more

Modern Meadow develops animal-free, bio-fabricated leather alternatives using synthetic biology and material science for the fashion, interiors, and automotive industries.

BiotechCircular EconomyNew MaterialsPine Brook, US

GFGabor Forgacs(Founder)inFrancoise Marga(Founder)inKaroly Jakab(Founder)inABAnna Bakst(Executive Officer, Director)inRex Liu(Executive Officer)DWDavid Williamson(CEO)in

Co-investorsARArtis VenturesASAstanor VenturesBRBreakout LabsCOCollaborative FundHOHorizons VenturesINInterplay Ventures Early Stage Management Llc+7 more

Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets.

AI & Machine LearningBiotechHealthtechSouth San Francisco, US

Jacob Rinaldi(Founder)inRonald Alfa(Executive Officer, Director, Promoter)RARon Alfa, MD, PhD(Co-Founder, CEO)inRon Alfa(Founder)Ron Alfa Jacob Rinaldi(Founder)

BoardJHJames Hardiman(Director)in

Co-investors1111.2 CapitalBRBreakout LabsCACatalio Capital Management, LPEPEPIC VENTURESINIntermountain HealthLILinearis Ventures+6 more

Quince Therapeutics is a clinical-stage biopharmaceutical company developing eDSP, an investigational therapy studied in a Phase 3 clinical trial (NEAT) for patients with Ataxia-Telangiectasia (A-T).

BiotechHealthtechWest Lafayette, US

Philip S. Low, Ph.D.(Executive Officer, Director)David Lamond(Director)Daniel Hasler(Director)Dirk Thye, M.D.(Executive Officer, Director)William J. Rutter(Director)Alex Andrianopoulos(Director)

Co-investorsELElevate VenturesPFPfizer Venture Investments

Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery.

AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US

RDRobert DiFazio(Founder)inJHJuliana Hilliard(Founder)injennifer lee(Vice President of Finance \u0026 Operations)Christopher Riling(Vice President of Science)

Co-investorsAIAIX VenturesGAGaingelsHUHumba VenturesIMImmeasurableJUJulian CapitalMEMetaplanet+19 more

Passkey operates Locksmith, a computational platform that uses human genetics, biology, and pharmacology to identify synergistic drug combinations from approved and late-stage drugs, allowing existing assets to be repurposed for new indications.

AI & Machine LearningBiotechDeep Tech

Co-investorsBIBison VenturesWIWireframe VenturesINInnovation Endeavors

Phantom Neuro develops neurotechnology for human-machine interaction, with a focus on applications for limb-loss and amputee populations.

AI & Machine LearningBiotechDeep TechMedical DevicesRoboticsAustin, US

CGConnor Glass(Executive Officer, Director, Promoter)in

BoardDWD.A. Wallach(Director)inEMEdward Michael(Director)inRLRobert Lord(Director)in

Co-investorsCACapital FactoryCRCrosscourt VenturesDRDraper AssociatesGAGaingelsLILionBirdTITime BioVentures+1 more

Technology identifying supply chain sources using the environmental microbiome.

Jessica Green(Founder)inHarrison Dillon(Founder)in

Co-investorsDODolby Family VenturesGOGolden SeedsJ-J-VenturesWEWestern Technology InvestmentWOWorking Capital FundAGAgFunder+4 more

Reach Industries builds a visual intelligence layer for science, combining AI, software, and hardware to support work in the life sciences.

AI & Machine LearningBiotechDeep TechRoboticsLondon, GB

CBChris Beck(Co-founder & CTO)inSASilas Adekunle(Co-founder & CEO)in

Co-investorsENEntrepreneur FirstLULunar VenturesPAPassion CapitalSOSOSVANAnorak VenturesIDId4 Ventures Limited+2 more

ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.

BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US

Robert Binney(Executive Officer, Director)

BoardJEJoyce Erony(Director)inZSZack Scott(Director)inBVBrad Vale(Director)inCTCasey Tansey(Director)MJMudit Jain(Executive Officer, Director)in

Co-investorsAMAmzak HealthAPAPERTURE Venture PartnersGLGlobal BioAccess FundNONorwest Venture PartnersOSOSF VenturesSESeroba Life Sciences+3 more

A biotech company developing novel biologics designed to target and eliminate the drivers of cancer recurrence and metastasis.

Biotech

Transfyr builds a sensor stack and multimodal AI models that record and analyze the physical execution of scientific experiments, capturing details that distinguish success from failure.

AI & Machine LearningBiotechDeep Tech

Co-investorsGEGeneral CatalystUNUnderscore VCLULux CapitalMVMVP VenturesNENeoSVSV Angel

ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields.

BiotechCircular EconomyClimate TechNew MaterialsSan Leandro, US

HCHarshal Chokhawala(Chief Executive Officer & Co-Founder)inLindy Fishburne(Director)Phil Grayeski(Director)Taehong Huh(Director)Timothy Dummer(Executive Officer, Director)Jon Kuchenreuther(Co-Founder)

Co-investorsACAccelr8BRBreakout LabsCACavallo VenturesDUDudley FundFRFreshTracks CapitalKDKdT Ventures+8 more